Acute Coronary Syndrome (ACS)

ACS refers to a sudden reduction or blockage of blood flow to the heart muscle from the coronary arteries that supply blood to the heart. Heart attack (myocardial infarction) and chest pain (angina) are two examples of acute coronary syndrome.

Quick Answer

What it is

ACS refers to a sudden reduction or blockage of blood flow to the heart muscle from the coronary arteries that supply blood to the heart. Heart attack (myocardial infarction) and chest pain (angina) are two examples of acute coronary syndrome.

Key findings

  • Grade A: Death/MI/Refractory Ischemia (Eptifibatide (Integrilin))
  • Grade A: Major Bleeding (Eptifibatide (Integrilin))
  • Grade B: Thrombocytopenia (Eptifibatide (Integrilin))

Safety

  • 1.5% absolute risk reduction.
  • ISMP high-risk medication.
ℹ️ Quick Facts

Quick Facts: Acute Coronary Syndrome (ACS)

  • Supplements Studied:2
  • Research Trials:1
  • Total Participants:63
  • Top Supplement:Curcumin (C)
1 trials
63 ppts
2 supps · 6 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

2-4g EPA+DHA daily (prescription-strength for triglyceride lowering)

Reduce triglycerides, anti-inflammatory, antiarrhythmic; may reduce cardiovascular mortality post-ACS

25 studies | 30,000 participants
100-300mg daily

Supports mitochondrial function in heart; may improve cardiac function and reduce oxidative stress post-ACS

15 studies | 2,000 participants

Supporting Stack (Tier 2)

300-400mg daily (avoid if kidney function impaired)

Supports cardiac rhythm, reduces arrhythmia risk; often depleted after ACS

12 studies | 1,500 participants
2000-4000 IU daily (target 40-60 ng/mL)

Deficiency associated with worse cardiovascular outcomes; may support cardiac recovery

10 studies | 2,000 participants
500-1000mg enhanced-absorption curcumin daily

Anti-inflammatory and antioxidant; may improve endothelial function and reduce post-ACS inflammation

8 studies | 500 participants
2-3g daily

Supports fatty acid metabolism in heart; may improve cardiac function and reduce mortality post-MI

10 studies | 3,000 participants
B-complex with folate 400-800mcg, B12 500-1000mcg, B6 25-50mg

Reduce homocysteine, a cardiovascular risk marker; support energy metabolism

10 studies | 5,000 participants
600-1200mg aged garlic extract daily

Antiplatelet, antihypertensive, reduces arterial plaque; supports cardiovascular health

8 studies | 600 participants

How It Works

Acute coronary syndrome (ACS) includes heart attack (STEMI and NSTEMI) and unstable angina - conditions caused by sudden reduction in blood flow to the heart, usually from a ruptured plaque and blood clot in a coronary artery. After an ACS event, the focus shifts to recovery and preventing another event (secondary prevention). Medical therapy is essential and includes antiplatelet drugs, statins, beta-blockers, and ACE inhibitors.

CRITICAL: This protocol is for RECOVERY and SECONDARY PREVENTION after an ACS event - NOT for treating an acute heart attack. If you have chest pain, pressure, or other symptoms of a heart attack, CALL 911 IMMEDIATELY. After ACS, medication adherence is crucial - supplements should COMPLEMENT, not replace, prescribed medications. Always inform your cardiologist about any supplements as some may interact with blood thinners or other cardiac medications.

* Omega-3 Fatty Acids have the strongest evidence for post-ACS support. The REDUCE-IT trial showed that prescription EPA (icosapent ethyl) significantly reduced cardiovascular events in high-risk patients. Omega-3s lower triglycerides, reduce inflammation, and may have antiarrhythmic effects.

* Coenzyme Q10 supports the heart's energy production. The heart requires enormous amounts of energy, and CoQ10 levels are often depleted after a cardiac event. Studies show CoQ10 may improve cardiac function and quality of life.

* Magnesium is essential for maintaining normal heart rhythm and is often low after ACS. Adequate magnesium levels are associated with better cardiovascular outcomes.

* Vitamin D deficiency is common and associated with worse outcomes after ACS. Maintaining adequate levels supports overall cardiovascular health.

* Curcumin has anti-inflammatory effects that may help reduce the ongoing inflammation after ACS and improve endothelial function.

* L-Carnitine helps the heart use fatty acids for energy. A meta-analysis found that L-carnitine supplementation after heart attack may reduce mortality and arrhythmias.

* B Vitamins help lower homocysteine, an amino acid linked to cardiovascular disease when elevated.

* Aged Garlic Extract has modest blood pressure lowering effects and may help slow plaque progression.

Expected timeline: Cardiac rehabilitation and recovery typically takes 3-6 months. Supplements support this process but benefits are cumulative over weeks to months. Secondary prevention is lifelong.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

|
A
Death/MI/Refractory Ischemia
PURSUIT (n=10,948): Composite endpoint 14.2% vs 15.7% placebo at 30 days (P=0.04). 1.5% absolute risk reduction. Benefit apparent by 96 hours. NNT=67 to prevent one event.
small↓Improves
A
Major Bleeding
SAFETY CONCERN: ESPRIT: Major bleeding 1.3% vs 0.4% placebo (P=0.027). PURSUIT: 2.1% vs 1.3%. Most bleeding at femoral access sites, mild. No increase in hemorrhagic stroke. ISMP high-risk medication.
small↑Worsens
B
Thrombocytopenia
SAFETY CONCERN: Significant thrombocytopenia (<20,000/ÎĽL) in 0.2% of patients in ESPRIT. Platelet monitoring recommended. Generally reversible upon discontinuation.
small↓Worsens
C
Myocardial Ischemia Protection (IV Administration)
A double-blind clinical trial found IV COP improved outcomes in patients with inadequate coronary circulation. Animal studies in rats and mice showed COP protected against isoprenaline-induced cardiac enzyme elevation and CaCl2-induced ventricular fibrillation. An in vitro NMR study in perfused Xenopus heart confirmed effects on cardiac energy metabolism. All evidence is from IV or direct perfusion, not oral dosing.
5 studies
moderate↓Improves
C
High-density lipoprotein (HDL)
Small Improvement
1 study
small↑Improves
?
Low-density lipoprotein (LDL)
1 study
↓Improves
?
Triglycerides
1 study
↓Improves

Research Citations (100)

Safety and efficacy of adjunctive tirofiban and eptifibatide in acute ischemic stroke: A systematic review and meta-analysis.
(2026)
PMID: 41500359
Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
(2025)
PMID: 41327719
Eptifibatide as an adjuvant therapy to thrombolysis versus thrombolysis alone in stroke management: a systematic review and meta-analysis of randomized controlled trials.
(2025)
PMID: 40544389
The Effect of Antioxidant Polyphenol Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis.
(2024)
PMID: 39683599
The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD: A Systematic Review and Meta-Analysis.
(2024)
PMID: 39723101
A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction.
(2023)
PMID: 36737382
Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial.
(2022)
PMID: 35039226
Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies.
(2022)
PMID: 34780001
Efficacy and Safety of Abbreviated Eptifibatide Treatment in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
(2021)
PMID: 33065082
Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects.
(2020)
PMID: 31197974

Related Conditions

Cardiovascular Disease

2 shared supplements · 223 outcomes

Cardiovascular disease (CVD) is a broad term that refers to various diseases of the heart and blood vessels. Atherosclerotic CVD (ASCVD) is the most common subtype of CVD and causes strokes and heart attacks.

Weight Loss & Maintenance

1 shared supplement · 433 outcomes

This goal refers to people with a BMI &gt;25 attempting to reach/maintain their ideal weight. While interventions that work for people with a BMI &gt;25 may also work for people with a lower BMI, the context is often sufficiently different that this isn't assured.

Ulcerative Colitis

1 shared supplement · 24 outcomes

Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) in which the immune system attacks the intestinal tract, resulting in inflammation and ulcers of the colon and rectum.

Type 2 Diabetes

1 shared supplement · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Systemic Lupus Erythematosus

1 shared supplement · 11 outcomes

Systemic Lupus Erythematosus (SLE or just Lupus) is an autoimmune disorder associated with outbreaks on skin tissue (and other immunological side-effects). Some supplements are thought to improve quality of life in persons with lupus.

Surgical Recovery

1 shared supplement · 43 outcomes

Surgical recovery refers to physiological endpoints after surgery including recovery time and adverse events including morbidity and mortality, as well as the presence of physical pain, physical comfort with everyday activities, physical independence, psychological support, and emotional well-being.

Rheumatoid Arthritis (RA)

1 shared supplement · 67 outcomes

Rheumatoid arthritis (RA) is an autoimmune disease that is mainly known for affecting the joints, but can also affect other parts of the body. It is more common in women than men and often starts during middle age, but it can occur at any age. The cause of RA is not well understood, but it seems to involve genetic, environmental, and hormonal factors.

Prostate Cancer

1 shared supplement · 34 outcomes

Prostate cancer is the second most common cancer in men. It usually grows very slowly and is unlikely to cause serious problems unless it spreads to other parts of the body. Western dietary patterns rich in dairy products seem to increase the risk of prostate cancer.